BioInformatics Reports on Capitalizing on New Opportunities for Stem Cell Products
09-Apr-2009 -
BioInformatics, LLC announced the release of its newest report, Capitalizing on New Opportunities for Stem Cell Products. As a result of the March 9, 2009 reversal of the 2001 restrictions on federal funding of human embryonic stem cell research, suppliers of stem cell related products are in ...
bioinformatics
diseases
Life Technologies
+9